Home/Filings/4/0001053369-15-000002
4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001053369-15-000002

$ELTPCIK 0001053369operating

Filed

Mar 8, 8:00 PM ET

Accepted

Mar 9, 2:45 PM ET

Size

5.1 KB

Accession

0001053369-15-000002

Insider Transaction Report

Form 4
Period: 2015-03-05
Ward Carter Julian
Chief Financial Officer
Transactions
  • Award

    common

    2015-03-05$0.34/sh+87,711$29,997963,293 total
Holdings
  • common

    (indirect: By IRA)
    1,355,014

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0001053369

Filing Metadata

Form type
4
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 2:45 PM ET
Size
5.1 KB